Freestone Grove Partners’s Lumexa Imaging Holdings LMRI Stock Holding History

Freestone Grove Partners’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23	Buy	+2	New	+$18	﹤0.01%	961

Other funds holding LMRI

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Freestone Grove Partners's LMRI Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Lumexa Imaging Holdings (LMRI) in Q2 2026: 2 shares worth $23. The stake represents ﹤0.01% of the portfolio and ranks #961 among its holdings.

103 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

Freestone Grove Partners held 2 shares of Lumexa Imaging Holdings worth $23 as of Q2 2026.
Lumexa Imaging Holdings was a new Freestone Grove Partners position in Q2 2026.
Lumexa Imaging Holdings made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #961 holding.
103 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.